Lariam (mefloquine) Important Safety Information from Roche as approved by the Irish Medicines Board

Notice type: 3rd Party Publications

Date: 08/07/2013

 

Problem Or Issue:
Important Safety Information communication from Roche on Lariam (mefloquine) for malaria chemoprophylaxis and the risk of neuropsychiatric adverse reactions.

Important Safety Information – Lariam (mefloquine)


« Back